Chemed (CHE) Receivables - Net (2009 - 2026)

Chemed has reported Receivables - Net for 18 years, with the latest figure at $215.5 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 24.62% year-over-year to $215.5 million; the trailing twelve-month figure through Mar 2026 stood at $215.5 million (down 24.62% YoY), and the FY2025 full-year result was $182.6 million, up 6.67% from the prior year.
• Receivables - Net for Q1 2026 stood at $215.5 million, up from $182.6 million in the prior quarter.
• The five-year high for Receivables - Net was $285.9 million in Q1 2025, with the low at $117.3 million in Q1 2022.
• Average Receivables - Net over 5 years is $173.7 million, with a median of $177.3 million recorded in 2024.
• Year-over-year, Receivables - Net jumped 61.21% in 2025 and decreased 24.62% in 2026.
• Tracing CHE's Receivables - Net over 5 years: stood at $139.4 million in 2022, then jumped by 30.2% to $181.5 million in 2023, then fell by 5.7% to $171.2 million in 2024, then gained by 6.67% to $182.6 million in 2025, then advanced by 18.02% to $215.5 million in 2026.
• The last three Receivables - Net figures came in at $215.5 million (Q1 2026), $182.6 million (Q4 2025), and $215.6 million (Q3 2025), per Business Quant data.

Peer Comparison